LifeStance Health Group (LifeStance Health Group) EBIT : $-167 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is LifeStance Health Group EBIT?

LifeStance Health Group's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-167 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. LifeStance Health Group's annualized ROC % for the quarter that ended in Mar. 2024 was -3.53%. LifeStance Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -15.94%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. LifeStance Health Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -6.30%.

LifeStance Health Group EBIT Historical Data

The historical data trend for LifeStance Health Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeStance Health Group EBIT Chart

LifeStance Health Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

13.28

-294.19

-212.80

-185.36

LifeStance Health Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial													-33.19	-46.90	-72.49	-32.78	-14.83

Competitive Comparison of LifeStance Health Group's EBIT

For the Medical Care Facilities subindustry, LifeStance Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LifeStance Health Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's EV-to-EBIT falls into.

LifeStance Health Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-167 Mil.

LifeStance Health Group (NAS:LFST) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

LifeStance Health Group's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-67.088 * ( 1 - -1.75% )	/	( (1942.57	+	1920.021)	/ 2 )
=	-68.26204	/	1931.2955
=	-3.53 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2109.969	-	144.541	-	( 78.824	-	max(0, 202.873	-	225.731	+	78.824	))
=	1942.57

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2106.316	-	149.642	-	( 49.451	-	max(0, 207.464	-	244.117	+	49.451	))
=	1920.021

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

LifeStance Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-59.324	/	( ( (358.925 + max(-9.726, 0))	+	(348.273 + max(36.931, 0)) )	/	2 )
=	-59.324	/	( ( 358.925	+	385.204 )	/	2 )
=	-59.324	/	372.0645
=	-15.94 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(125.405	+	0	+	21.267)	-	(144.541	+	0	+	11.857)
=	-9.726

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(175.937	+	0	+	18.729)	-	(149.642	+	0	+	8.093)
=	36.931

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

LifeStance Health Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-167.007	/	2651.558
	=	-6.30 %

LifeStance Health Group EBIT Related Terms

Thank you for viewing the detailed overview of LifeStance Health Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeStance Health Group (LifeStance Health Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeStance Health Group Inc (NAS:LFST) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

4800 North Scottsdale Road, Suite 6000, Scottsdale, AZ, USA, AZ 85251

Website

https://www.lifestance.com

LifeStance Health Group Inc is a provider of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.

Executives

Kevin Michael Mullins	officer: Chief Development Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Paula Cipollone	officer: See Remarks	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Warren Gouk	officer: Chief Administrative Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ann Varanakis	officer: Chief People Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Anisha Patel-dunn	officer: Chief Medical Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ryan Pardo	officer: See Remarks	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Danish J. Qureshi	officer: Chief Growth Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Pablo Pantaleoni	officer: Chief Digital Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
David Bourdon	officer: Chief Financial Officer	6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Kenneth A Burdick	director, officer: Chief Executive Officer	6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Felicia Gorcyca	officer: Chief People Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Michael K. Lester	director, officer: See Remarks	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Gwen H. Booth	officer: Chief Operating Officer	4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Jesse Michael Bruff	officer: Chief Financial Officer	3100 HANSEN WAY, PALO ALTO CA 94304
Tpg Gp A, Llc	10 percent owner	301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102